![](/img/cover-not-exists.png)
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL
Savino, A M, Sarno, J, Trentin, L, Vieri, M, Fazio, G, Bardini, M, Bugarin, C, Fossati, G, Davis, K L, Gaipa, G, Izraeli, S, Meyer, L H, Nolan, G P, Biondi, A, Te Kronnie, G, Palmi, C, Cazzaniga, GLanguage:
english
Journal:
Leukemia
DOI:
10.1038/leu.2017.93
Date:
March, 2017
File:
PDF, 2.10 MB
english, 2017